A. Cushman-Vokoun

发表

Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology

Robyn L. Temple-Smolkin, D. Sargent, Christina B. Ventura, 2017 .

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.

Robyn L. Temple-Smolkin, D. Sargent, Carol Colasacco, 2017, Archives of pathology & laboratory medicine.

Molecular Biomarkers for the Evaluation of Colorectal Cancer

Robyn L. Temple-Smolkin, D. Sargent, Christina B. Ventura, 2017, American journal of clinical pathology.

Robyn L. Temple-Smolkin, D. Sargent, Christina B. Ventura, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Robyn L. Temple-Smolkin, D. Sargent, Christina B. Ventura, 2017, The Journal of molecular diagnostics : JMD.

Regulation of the vav proto-oncogene by LKLF.

R. Kawahara, A. Cushman-Vokoun, D. J. Denkinger, 2001, Gene.

Exploring the prognostic and therapeutic utility of expanded mutation profiling in appendix peritoneal metastasis managed with CRS/HIPEC

V. Shostrom, J. Foster, S. McDermott, 2021, Journal of surgical oncology.

QIAGEN Therascreen KRAS RGQ Assay, QIAGEN KRAS Pyro Assay, and Dideoxy Sequencing for Clinical Laboratory Analysis of KRAS Mutations in Tumor Specimens.

A. Cushman-Vokoun, Qamra M Alqahtani, A. Crowley, 2016, Laboratory medicine.

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline Summary From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.

Robyn L. Temple-Smolkin, D. Sargent, Christina B. Ventura, 2017, Journal of oncology practice.

Preanalytics and Precision Pathology: Pathology Practices to Ensure Molecular Integrity of Cancer Patient Biospecimens for Precision Medicine.

Matthew W. Anderson, C. Compton, K. Bloom, 2019, Archives of pathology & laboratory medicine.

Assay design affects the interpretation of T-cell receptor gamma gene rearrangements: comparison of the performance of a one-tube assay with the BIOMED-2-based TCRG gene clonality assay.

T. Greiner, A. Cushman-Vokoun, S. Connealy, 2010, The Journal of molecular diagnostics : JMD.

PU.1 regulates the expression of the Vav proto‐oncogene

R. Kawahara, A. Cushman-Vokoun, D. J. Denkinger, 2002, Journal of cellular biochemistry.

Co-infection of COVID-19 and influenza A in a hemodialysis patient: a case report

E. Schnaubelt, R. Vunnam, A. Cushman-Vokoun, 2020, BMC Infectious Diseases.

Molecular Advances in Nodal Peripheral T-Cell Lymphoma

A. Cushman-Vokoun, Safina Hafeez, 2022, Advances in Molecular Pathology.

Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2

M. J. Broadhurst, P. Fey, S. Hinrichs, 2020, Journal of Clinical Virology.

Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing.

J. Berlin, C. Vnencak-Jones, Zhiguo Zhao, 2013, Clinical colorectal cancer.

Somatic Alterations and Targeted Therapy

A. Cushman-Vokoun, 2012 .

Molecular diagnostics of soft tissue tumors.

J. Bridge, A. Cushman-Vokoun, 2011, Archives of pathology & laboratory medicine.

Comparison study of the performance of the QIAGEN EGFR RGQ and EGFR pyro assays for mutation analysis in non-small cell lung cancer.

T. Greiner, A. Cushman-Vokoun, A. Crowley, 2013, American journal of clinical pathology.

Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non–Small-Cell Lung Cancer

Lynette M. Smith, A. Kessinger, A. Ganti, 2016, Journal of global oncology.

EGFR Exon 20 Insertion in Bithalamic and Unithalamic Glioma: A Report of 2 Cases and Literature Review.

N. Shonka, M. Abromowitch, M. Punsoni, 2022, Journal of neuropathology and experimental neurology.

A Model Information Management Plan for Molecular Pathology Sequence Data Using Standards: From Sequencer to Electronic Health Record.

Alexis B. Carter, James R. Campbell, James R Campbell, 2019, The Journal of molecular diagnostics : JMD.

The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm

T. Greiner, K. Fu, Weiwei Zhang, 2021, International journal of laboratory hematology.

Predicted influence of sample hematocrit on injected mass of internal standard in mass spectrometry assays utilizing simple protein precipitation for sample preparation

J. Landmark, D. Stickle, A. Cushman-Vokoun, 2007, Clinical chemistry and laboratory medicine.

The Missing LNK: Evolution from Cytosis to Chronic Myelomonocytic Leukemia in a Patient with Multiple Sclerosis and Germline SH2B3 Mutation

B. Dave, V. Bhatt, L. Maness, 2022, Case reports in genetics.

Laboratory and Clinical Implications of Incidental and Secondary Germline Findings During Tumor Testing.

Marilyn M. Li, Brad W Jensen, J. Myles, 2021, Archives of pathology & laboratory medicine.

Standards for Clinical Grade Genomic Databases.

Alexis B. Carter, John D Pfeifer, J. M. Crawford, 2015, Archives of pathology & laboratory medicine.

Mucinous Adenocarcinoma of the Appendix With Histologic Response to Neoadjuvant Chemotherapy: Review of Histologic and Clinical Spectrum of Epithelial Neoplastic Mucinous Lesions of the Appendix.

Adam J. Horn, A. Cushman-Vokoun, J. Padussis, 2021, Oncology.

Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing.

J. Berlin, C. Vnencak-Jones, Zhiguo Zhao, 2013, Clinical colorectal cancer.